FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Jean-François Fonteneau

Research Profile

Anatomy

Physiology

Chemicals & Drugs

Disorders

Melanoma

Procedures

Flow Cytometry

Co-author Network

Publications

TOP 3
Jean-Baptiste GUILLERME; Jérémie Ménager; David Roulois; Frédéric Tangy; Nicolas Boisgerault; Chantal Combredet; Jean-François Fonteneau; Marc Gregoire
Measles virus vaccine-infected tumor cells induce tumor antigen cross-presentation by human plasmacytoid dendritic cells.
Nicolas Boisgerault; Chantal Combredet; Jean-François Fonteneau; Jean-Baptiste GUILLERME; Mariana Mesel-Lemoine; Daniel Pouliquen; Frédéric Tangy; Carole Achard; Marc Grégoire
Natural oncolytic activity of live-attenuated measles virus against human lung and colorectal adenocarcinomas.
David Roulois; Marc Grégoire; Jean-François Fonteneau
MUC1-specific cytotoxic T lymphocytes in cancer therapy: induction and challenge.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Jean-François Fonteneau (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Jean-Baptiste GUILLERME; Jérémie Ménager; David Roulois; Frédéric Tangy; Nicolas Boisgerault; Chantal Combredet; Jean-François Fonteneau; Marc Gregoire
Measles virus vaccine-infected tumor cells induce tumor antigen cross-presentation by human plasmacytoid dendritic cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2013;19(5):1147-58.
2013: Nicolas Boisgerault; Chantal Combredet; Jean-François Fonteneau; Jean-Baptiste GUILLERME; Mariana Mesel-Lemoine; Daniel Pouliquen; Frédéric Tangy; Carole Achard; Marc Grégoire
Natural oncolytic activity of live-attenuated measles virus against human lung and colorectal adenocarcinomas.
BioMed research international 2013;2013():387362.
2013: David Roulois; Marc Grégoire; Jean-François Fonteneau
MUC1-specific cytotoxic T lymphocytes in cancer therapy: induction and challenge.
BioMed research international 2013;2013():871936.
2012: Delphine Coulais; Jean-François Fonteneau; Clarisse Panterne; Marc Grégoire
Purification of circulating plasmacytoid dendritic cells using counterflow centrifugal elutriation and immunomagnetic beads.
Cytotherapy 2012;14(7):887-96.
2012: David Roulois; Christophe Blanquart; Marc Grégoire; Fabien Gueugnon; Clarisse Panterne; Jean-François Fonteneau
Downregulation of MUC1 expression and its recognition by CD8⁺ T cells on the surface of malignant pleural mesothelioma cells treated with HDACi.
European journal of immunology 2012;42(3):783-9.
2012: Thomas Simon; Séverine Tanguy-Royer; Pierre-Joseph Royer; Nicolas Boisgerault; Jean-François Fonteneau; Jihane Frikeche; Marc Grégoire
Human dendritic cells sequentially matured with CD4(+) T cells as a secondary signal favor CTL and long-term T memory cell responses.
Biological research 2012;45(1):33-43.
2011: S Leclercq; M Padieu; D Pouliquen; A Rogel; C Blanquart; B Boutin; Jean-François Fonteneau; Fabien Gueugnon; F Guillot; M Grégoire
A 5-aza-2'-deoxycytidine/valproate combination induces cytotoxic T-cell response against mesothelioma.
The European respiratory journal 2011;38(5):1105-16.
2011: D Roulois; Virginie Vignard; M Grégoire; Fabien Gueugnon; Nathalie Labarrière; Jean-François Fonteneau
Recognition of pleural mesothelioma by mucin-1(950-958)/human leukocyte antigen A*0201-specific CD8+ T-cells.
The European respiratory journal 2011;38(5):1117-26.
2011: Flora Guillot; Myriam Robard; Christophe Blanquart; Benoît Boutin; Jean-François Fonteneau; Marc Grégoire; Daniel Pouliquen
Vaccination with epigenetically treated mesothelioma cells induces immunisation and blocks tumour growth.
Vaccine 2011;29(33):5534-43.
2009: Thomas Simon; Jean-François Fonteneau; Marc Grégoire
Dendritic cell preparation for immunotherapeutic interventions.
Immunotherapy 2009;1(2):289-302.
2008: Pierre Larrieu; Virginie Renaud; yann godet; Francine Jotereau; Jean-François Fonteneau
A HLA-Cw*0701 restricted Melan-A/MART1 epitope presented by melanoma tumor cells to CD8+ tumor infiltrating lymphocytes.
Cancer immunology, immunotherapy : CII 2008;57(5):745-52.
2007: Pierre Larrieu; Laure-Hélène Ouisse; Yannick Guilloux; Francine Jotereau; Jean-François Fonteneau
A HLA-DQ5 restricted Melan-A/MART-1 epitope presented by melanoma tumor cells to CD4+ T lymphocytes.
Cancer immunology, immunotherapy : CII 2007;56(10):1565-75.
2007: Oruganti Srinivas; Pierre Larrieu; Eric Duverger; Claire Boccaccio; Marie-Thérèse Bousser; Michel Monsigny; Jean-François Fonteneau; Francine Jotereau; Annie-Claude Roche
Synthesis of glycocluster-tumor antigenic peptide conjugates for dendritic cell targeting.
Bioconjugate chemistry 2007;18(5):1547-54.
2005: Marion Subklewe; Kathrin Sebelin; Andrea Block; Antje Meier; Anna Roukens; Casper Paludan; Jean-François Fonteneau; Ralph M Steinman; Christian Münz
Dendritic cells expand Epstein Barr virus specific CD8+ T cell responses more efficiently than EBV transformed B cells.
Human immunology 2005;66(9):938-49.
2004: Jean-François Fonteneau; Marie Larsson; Anne-Sophie Beignon; Kelli McKenna; Ida Dasilva; Ali Amara; Yong-Jun Liu; Jeffrey D Lifson; Dan R Littman; Nina Bhardwaj
Human immunodeficiency virus type 1 activates plasmacytoid dendritic cells and concomitantly induces the bystander maturation of myeloid dendritic cells.
Journal of virology 2004;78(10):5223-32.
2003: Jean-François Fonteneau; Daniel G Kavanagh; Margareta Lirvall; Catherine Sanders; Timothy L Cover; Nina Bhardwaj; Marie Larsson
Characterization of the MHC class I cross-presentation pathway for cell-associated antigens by human dendritic cells.
Blood 2003;102(13):4448-55.
2003: Jean-François Fonteneau; Michel Gilliet; Marie Larsson; Ida Dasilva; Christian Münz; Yong-Jun Liu; Nina Bhardwaj
Activation of influenza virus-specific CD4+ and CD8+ T cells: a new role for plasmacytoid dendritic cells in adaptive immunity.
Blood 2003;101(9):3520-6.
2003: Marie Larsson; Jean-François Fonteneau; Nina Bhardwaj
Cross-presentation of cell-associated antigens by dendritic cells.
Current topics in microbiology and immunology 2003;276():261-75.
2002: Andrew W Lee; Tuan Truong; Kara Bickham; Jean-François Fonteneau; Marie Larsson; Ida Da Silva; Selin Somersan; Elaine K Thomas; Nina Bhardwaj
A clinical grade cocktail of cytokines and PGE2 results in uniform maturation of human monocyte-derived dendritic cells: implications for immunotherapy.
Vaccine 2002;20 Suppl 4():A8-A22.
2002: Casper Paludan; Kara Bickham; Sarah Nikiforow; Ming L Tsang; Kiera Goodman; Willem A Hanekom; Jean-François Fonteneau; Stefan Stevanović; Christian Münz
Epstein-Barr nuclear antigen 1-specific CD4(+) Th1 cells kill Burkitt's lymphoma cells.
Journal of immunology (Baltimore, Md. : 1950) 2002;169(3):1593-603.
2002: Jean-François Fonteneau; Marie Larsson; Nina Bhardwaj
Interactions between dead cells and dendritic cells in the induction of antiviral CTL responses.
Current opinion in immunology 2002;14(4):471-7.
2002: Marie Larsson; Jean-François Fonteneau; Margareta Lirvall; Patrick A J Haslett; Jeffrey D Lifson; Nina Bhardwaj
Activation of HIV-1 specific CD4 and CD8 T cells by human dendritic cells: roles for cross-presentation and non-infectious HIV-1 virus.
AIDS (London, England) 2002;16(10):1319-29.
2002: Marie Larsson; David T Wilkens; Jean-François Fonteneau; Thomas J Beadle; Melissa J Merritt; Rhonda Kost; Patrick A J Haslett; Susan Cu-Uvin; Nina Bhardwaj; Douglas F Nixon; Barbara L Shacklett
Amplification of low-frequency antiviral CD8 T cell responses using autologous dendritic cells.
AIDS (London, England) 2002;16(2):171-80.
2001: Marie Larsson; Jean-François Fonteneau; Selin Somersan; Catherine Sanders; Kara Bickham; Elaine K Thomas; Karsten Mahnke; Nina Bhardwaj
Efficiency of cross presentation of vaccinia virus-derived antigens by human dendritic cells.
European journal of immunology 2001;31(12):3432-42.
2001: Jean-François Fonteneau; Marie Larsson; Selin Somersan; Catherine Sanders; Christian Münz; W W Kwok; Nina Bhardwaj; Francine Jotereau
Generation of high quantities of viral and tumor-specific human CD4+ and CD8+ T-cell clones using peptide pulsed mature dendritic cells.
Journal of immunological methods 2001;258(1-2):111-26.
2001: Selin Somersan; Marie Larsson; Jean-François Fonteneau; S Basu; P Srivastava; Nina Bhardwaj
Primary tumor tissue lysates are enriched in heat shock proteins and induce the maturation of human dendritic cells.
Journal of immunology (Baltimore, Md. : 1950) 2001;167(9):4844-52.
2001: Jean-François Fonteneau; M Larsson; N Bhardwaj
Dendritic cell-dead cell interactions: implications and relevance for immunotherapy.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2001;24(4):294-304.
2001: Marie Larsson; Jean-François Fonteneau; Nina Bhardwaj
Dendritic cells resurrect antigens from dead cells.
Trends in immunology 2001;22(3):141-8.
2001: Kara Bickham; Christian Münz; Ming L Tsang; Marie Larsson; Jean-François Fonteneau; Nina Bhardwaj; R Steinman
EBNA1-specific CD4+ T cells in healthy carriers of Epstein-Barr virus are primarily Th1 in function.
The Journal of clinical investigation 2001;107(1):121-30.
2000: Madhav V Dhodapkar; James W Young; Paul B Chapman; W I Cox; Jean-François Fonteneau; S Amigorena; Alan N Houghton; Ralph M Steinman; Nina Bhardwaj
Paucity of functional T-cell memory to melanoma antigens in healthy donors and melanoma patients.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(12):4831-8.
2000: Marie Larsson; Davorka Messmer; Selin Somersan; Jean-François Fonteneau; Sean M Donahoe; M Lee; P R Dunbar; V Cerundolo; I Julkunen; Douglas F Nixon; Nina Bhardwaj
Requirement of mature dendritic cells for efficient activation of influenza A-specific memory CD8+ T cells.
Journal of immunology (Baltimore, Md. : 1950) 2000;165(3):1182-90.
2000: Nadine Gervois; Nathalie Labarriere; S Le Guiner; Marie-Christine Pandolfino; Jean-François Fonteneau; Yannick Guilloux; Elisabeth Diez; Brigitte Dreno; Francine Jotereau
High avidity melanoma-reactive cytotoxic T lymphocytes are efficiently induced from peripheral blood lymphocytes on stimulation by peptide-pulsed melanoma cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(4):1459-67.
1999: Danila Valmori; Jean-François Fonteneau; Salvatore Valitutti; Nadine Gervois; R Dunbar; Danielle Liénard; Donata Rimoldi; Vincenzo Cerundolo; Francine Jotereau; Jean-Charles Cerottini; Daniel E Speiser; Pedro Romero
Optimal activation of tumor-reactive T cells by selected antigenic peptide analogues.
International immunology 1999;11(12):1971-80.
1998: Danila Valmori; Nadine Gervois; Donata Rimoldi; Jean-François Fonteneau; Anilza Bonelo; Danielle Liénard; L Rivoltini; Francine Jotereau; Jean-Charles Cerottini; Pedro Romero
Diversity of the fine specificity displayed by HLA-A*0201-restricted CTL specific for the immunodominant Melan-A/MART-1 antigenic peptide.
Journal of immunology (Baltimore, Md. : 1950) 1998;161(12):6956-62.
1998: S Le Guiner; E Le Dréan; Nathalie Labarrière; Jean-François Fonteneau; C Viret; Elisabeth Diez; Francine Jotereau
LFA-3 co-stimulates cytokine secretion by cytotoxic T lymphocytes by providing a TCR-independent activation signal.
European journal of immunology 1998;28(4):1322-31.
1998: Danila Valmori; Jean-François Fonteneau; C M Lizana; Nadine Gervois; Danielle Liénard; Donata Rimoldi; Victor Jongeneel; Francine Jotereau; Jean-Charles Cerottini; Pedro Romero
Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues.
Journal of immunology (Baltimore, Md. : 1950) 1998;160(4):1750-8.
1997: Jean-François Fonteneau; E Le Dréan; S Le Guiner; Nadine Gervois; Elisabeth Diez; Francine Jotereau
Heterogeneity of biologic responses of melanoma-specific CTL.
Journal of immunology (Baltimore, Md. : 1950) 1997;159(6):2831-9.
1997: Nathalie Labarriere; Elisabeth Diez; Marie-Christine Pandolfino; C Viret; Yannick Guilloux; S Le Guiner; Jean-François Fonteneau; Brigitte Dreno; Francine Jotereau
Optimal T cell activation by melanoma cells depends on a minimal level of antigen transcription.
Journal of immunology (Baltimore, Md. : 1950) 1997;158(3):1238-45.